The description of new dopamine (DA) receptor subtypes, D1-(D1 and D5) and D2-like
(D2A, D2B, D3, D4), has given an impetus to DA research. While selective agonists and …

Reverse Transcriptase-Polymerase Chain Reaction technique was used to determine the
levels of the mRNAs encoding different receptors belonging to the D2 family in various brain …

To study the effects of altering dopaminergic input on the levels and rate of synthesis of
dopamine receptors, corpora striata of mice were lesioned unilaterally with 6 …

The leucocyte specific transcript—1 (LST1) represents the human homolog of the mouse
B144 transcript, encoded within the tumor necrosis factor (TNF) region of the human major …

Hypophonia is an early symptom in Parkinson's disease (PD) that involves an increase in
laryngeal muscle activity, interfering with voice production. Our aim was to use an animal …

The antisense strategy was used to unravel the functional contribution of the mRNAs
encoding dopamine (DA) receptors to the multiple transduction mechanisms operated by DA …

The amplification of cyclic nucleotide 'second messenger'signals within neurons is
controlled by phosphodiesterases which are responsible for their degradation. Calmodulin …

3, 4‐Dihydroxyphenylethylamine (dopamine) D2 receptor agonists, including BHT 920 and
bromocriptine, and the potassium channel opener minoxidil share the property of …

Stimulation of a D4-like dopamine (DA) receptors inhibits a cAMP-dependent increase in
serotonin N-acetyltransferase activity and melatonin biosynthesis in the chick retina. In order …

Publisher Summary This chapter discusses the perspectives in the design and application of
dopamine receptor agonists. The chapter discusses main pharmacological and clinical …